BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37169640)

  • 1. Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study.
    Crump C; Stattin P; Brooks JD; Sundquist J; Bill-Axelson A; Edwards AC; Sundquist K; Sieh W
    Eur Urol; 2023 Sep; 84(3):263-272. PubMed ID: 37169640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of depression, anxiety, and suicide in partners of men with prostate cancer: a national cohort study.
    Crump C; Stattin P; Brooks JD; Sundquist J; Edwards AC; Sundquist K; Sieh W
    J Natl Cancer Inst; 2024 May; 116(5):745-752. PubMed ID: 38060258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality Risks Associated with Depression in Men with Prostate Cancer.
    Crump C; Stattin P; Brooks JD; Sundquist J; Sieh W; Sundquist K
    Eur Urol Oncol; 2024 Apr; ():. PubMed ID: 38575410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study.
    Crump C; Stattin P; Brooks JD; Sundquist J; Edwards AC; Sieh W; Sundquist K
    JNCI Cancer Spectr; 2023 Jul; 7(4):. PubMed ID: 37389442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy.
    Deka R; Rose BS; Bryant AK; Sarkar RR; Nalawade V; McKay R; Murphy JD; Simpson DR
    Cancer; 2019 Apr; 125(7):1070-1080. PubMed ID: 30748008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy.
    Raldow AC; Zhang D; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
    Brachytherapy; 2015; 14(6):781-7. PubMed ID: 26361718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of fracture incidence in prostate cancer survivors: a nationwide cohort study in South Korea.
    Shin HB; Park HS; Yoo JE; Han K; Park SH; Shin DW; Park J
    Arch Osteoporos; 2020 Jul; 15(1):110. PubMed ID: 32700143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of Depression and Suicide After Diagnosis With Heart Failure: A National Cohort Study.
    Crump C; Sundquist J; Kendler KS; Sieh W; Edwards AC; Sundquist K
    JACC Heart Fail; 2022 Nov; 10(11):819-827. PubMed ID: 36328649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Comorbidity on the Risk of Mortality in Men With Unfavorable-Risk Prostate Cancer Undergoing High-Dose Radiation Therapy Alone.
    Huynh MA; Chen MH; Wu J; Braccioforte MH; Moran BJ; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1158-67. PubMed ID: 27209511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race and mortality risk after radiation therapy in men treated with or without androgen-suppression therapy for favorable-risk prostate cancer.
    Kovtun KA; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
    Cancer; 2016 Dec; 122(23):3608-3614. PubMed ID: 27490845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease.
    Keane FK; Chen MH; Zhang D; Moran BJ; Braccioforte MH; D'Amico AV
    Cancer; 2015 Aug; 121(16):2713-9. PubMed ID: 25925789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer.
    Nguyen C; Lairson DR; Swartz MD; Du XL
    Pharmacotherapy; 2018 Oct; 38(10):999-1009. PubMed ID: 30080934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen nadir and testosterone level at prostate-specific antigen failure following radiation and androgen suppression therapy for unfavorable-risk prostate cancer and the risk of all-cause and prostate cancer-specific mortality.
    Bitterman DS; Chen MH; Wu J; Renshaw AA; Loffredo M; Kantoff PW; Small EJ; D'Amico AV
    Cancer; 2021 Aug; 127(15):2623-2630. PubMed ID: 33823065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy.
    Zumsteg ZS; Spratt DE; Pei X; Yamada Y; Kalikstein A; Kuk D; Zhang Z; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1012-7. PubMed ID: 22981709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gleason Score 3 + 5 or 5 + 3 versus 4 + 4 Prostate Cancer: The Risk of Death.
    Huynh MA; Chen MH; Wu J; Braccioforte MH; Moran BJ; D'Amico AV
    Eur Urol; 2016 Jun; 69(6):976-9. PubMed ID: 26388503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials.
    Atkins KM; Chen MH; Wu J; Renshaw AA; Loffredo M; Kantoff PW; Small EJ; D'Amico AV
    Cancer; 2018 Apr; 124(7):1383-1390. PubMed ID: 29266181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy.
    Tully KH; Nguyen DD; Herzog P; Jin G; Noldus J; Nguyen PL; Kibel AS; Sun M; McGregor B; Basaria S; Trinh QD
    Eur Urol Oncol; 2021 Feb; 4(1):66-72. PubMed ID: 31624049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT).
    Wilt TJ; Vo TN; Langsetmo L; Dahm P; Wheeler T; Aronson WJ; Cooperberg MR; Taylor BC; Brawer MK
    Eur Urol; 2020 Jun; 77(6):713-724. PubMed ID: 32089359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Bill-Axelson A;
    Eur Urol Oncol; 2018 Jun; 1(2):134-142. PubMed ID: 31100237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial.
    Ilie G; Rendon R; Mason R; MacDonald C; Kucharczyk MJ; Patil N; Bowes D; Bailly G; Bell D; Lawen J; Ha M; Wilke D; Massaro P; Zahavich J; Kephart G; Rutledge RDH
    Eur Urol; 2023 Jun; 83(6):561-570. PubMed ID: 36822969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.